New statistics reveal need for legal reform to tackle Korea’s lack of progress in reducing animal testing
SEOUL—Humane Society International/Korea is calling on
legislators to back a series of tough new legal measures to address the lack of
progress by Korea’s relevant regulatory and research funding ministries toward
reduction and replacement of animal testing. Statistics on laboratory animal
use in 2019 published this week by Korea’s Ministry of Agriculture, Food and
Rural Affairs’ Animal and Plant Quarantine Agency[1] revealed a marginal 0.4%
decrease in total animal use compared to the previous year (3,712,380 in 2019
compared to 3,727,163 in 2018), together with alarming increases in animal use
for testing insecticides (+187%), industrial chemicals (+115%), education and
training (+77.8%), pharmaceutical quality control testing (+40%), production of
genetically modified animals (+12%), and experiments in the most severe pain
category (+9.7%).
Borami Seo, HSI/Korea senior policy manager for research and
toxicology, said: “These statistics make it clear far Korean authorities and
science funding ministries have to go to fulfill their stated commitment to
replace, reduce or even minimize the most severe suffering in animal testing.
The future lies in human mimetic non-animal approaches like human organoids,
organs-on-chips and next-generation computing and AI, not in poisoning or
genetically modifying mice, monkeys and other animals. It’s time our government
followed the example of the United States, the Netherlands and other innovation
economies by making a serious investment in non-animal technologies to advance
safety science and medical research.”
HSI/Korea has been working with members of the National
Assembly and key ministries to make research and regulatory testing with
non-animal approaches a higher priority. For example, Korean chemical,
pesticide and pharmaceutical authorities should reflect on their performance in
comparison to the US Environmental Protection Agency’s commitment to
reduce mammalian testing requirements by 30% by 2025 and to completely
eliminate them by 2035. Korean science funding ministries should look to European and American funding
programs for organ-on-a-chip technologies to advance drug testing and human
disease research.
Assembly member In-soon Nam and HSI will host an Assembly
forum on June 30 to discuss a new legislative initiative to promote the
development, distribution, and use of alternatives to animal testing methods.
Presenters include officials from the Ministry of Food and Drug Safety and the
Ministry of Health and Welfare, the president of the Korea Institute of
Toxicology Chang-Woo Song, the vice president of the Korean Society for
Alternative to Animal Experiments Gwang-Man Kim, CEO of Dana Green Bio Ki-woo
Kim, and HSI/Korea. Additionally, legal experts from the National Assembly’s
Legislative office, the Korea Legislation Research Institute and the Korean
lawyers’ group People for Non-Human Rights will join the discussion.
📌 Visit Us:
🌐 Website: https://statisticsaward.com/
🏆
Nomination: https://statisticsaward.com/award-nomination/?ecategory=Awards&rcategory=Awardee
📝
Registration: https://statisticsaward.com/award-registration/
Comments
Post a Comment